Efficacy and safety of fezolinetant, a neurokinin-3 antagonist, in treating vasomotor symptoms in postmenopausal women: A systematic review and meta-analysis.

Medicine (Baltimore) · 2023 · PMC10727556 · PMID 38115258

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a slightly increasing trendno p-value reported

[ 27 ] A slightly increasing trend of hepatotoxicity was also seen in fezolinetant group.

also in 255 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.